-
Robot wrote a new post, CytoDyn Inc. (CYDY: OTCQB) | CytoDyn Appoints Dr. Scott A. Kelly as Chairman of the Board 4 days, 15 hours ago
-
Robot wrote a new post, CytoDyn Inc. (CYDY: OTCQB) | CytoDyn to Hold Investment Community Conference Call on December 12, 2018 1 week, 3 days ago
-
Robot wrote a new post, CytoDyn Inc. (CYDY: OTCQB) | CytoDyn’s Prostate Cancer Prognostic Test Demonstrates Substantial Added Value to Gleason Score in Predicting Patient Outcomes 2 weeks, 3 days ago
-
Robot wrote a new post, CytoDyn Inc. (CYDY: OTCQB) | CytoDyn to Present at Two Investment Conferences in December 2 weeks, 5 days ago
-
Robot wrote a new post, CytoDyn Inc. (CYDY: OTCQB) | CytoDyn Announces Initiation of Metastatic Triple Negative Breast Cancer Trial and Reiterates Phase 3 Goal in Cancer 2 weeks, 6 days ago
-
Robot wrote a new post, CytoDyn Inc. (CYDY: OTCQB) | USAN Council Assigns Leronlimab as the Official Name for CytoDyn’s PRO 140 3 weeks, 5 days ago
-
Robot wrote a new post, CytoDyn Inc. (CYDY: OTCQB) | USAN Council Assigns Leronlimab as the Official Name for CytoDyn’s PRO 140 3 weeks, 5 days ago
-
Robot wrote a new post, CytoDyn Inc. (CYDY: OTCQB) | CytoDyn’s PRO 140 (leronlimab) HIV Monotherapy Trial Results Show 92% Responder’s Rate at 700 mg Dose 1 month ago
- Load More
$CYDY